Cargando…
SARS-CoV-2 infection and COVID19 vaccination across eight immune-mediated inflammatory disorders: A prospective, real-life Belgian cohort study – the BELCOMID study
BACKGROUND: The risks and impact of COVID19 disease and vaccination in patients with Immune Mediated Inflammatory Diseases (IMID) remain incompletely understood. IMID patients and particularly patients receiving immunosuppressive treatment were excluded from the original, registrational phase-3 COVI...
Autores principales: | Geldof, Jeroen, Truyens, Marie, Sabino, João, Ferrante, Marc, Lambert, Jo, Lapeere, Hilde, Hillary, Tom, Van Laethem, An, de Vlam, Kurt, Verschueren, Patrick, Padalko, Elizaveta, Lobaton, Triana, Vermeire, Séverine |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10014825/ https://www.ncbi.nlm.nih.gov/pubmed/36936974 http://dx.doi.org/10.3389/fimmu.2023.1126351 |
Ejemplares similares
-
067 BELCOMID: BELgian Cohort study of COVID-19 in Immune Mediated Inflammatory Diseases
por: Hillary, T., et al.
Publicado: (2021) -
34296 Introduction of BELCOMID: BELgian Cohort study of COVID-19 in Immune Mediated Inflammatory Diseases
por: Hillary, Tom, et al.
Publicado: (2022) -
Human bocavirus infection in Belgian children with respiratory tract disease
por: Verbeke, Vanessa, et al.
Publicado: (2019) -
New biologics and small molecules in inflammatory bowel disease: an
update
por: Sabino, João, et al.
Publicado: (2019) -
Biological tests carried out on serum/plasma samples from donors of human body material for transplantation: Belgian experience and practical recommendations
por: Padalko, Elizaveta, et al.
Publicado: (2018)